Novel fusion transcripts associate with progressive prostate cancer

American Journal of Pathology

Volumn 184, Issue 10, 2014, Pages 2840-2849

  Yu, Yan P ^a   Ding, Ying ^a   Chen, Zhanghui ^a   Liu, Silvia ^a   Michalopoulos, Amantha ^a   Chen, Rui ^a   Gulzar, Zulfiqar G ^b   Yang, Bing ^c   Cieply, Kathleen M ^a   Luvison, Alyssa ^a   Ren, Bao Guo ^a   Brooks, James D ^b   Jarrard, David ^c   Nelson, Joel B ^a   Michalopoulos, George K ^a   Tseng, George C ^a   Luo, Jian Hua ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME; MESSENGER RNA;

AC011523 2 GENE; AMACR GENE; ARTICLE; C5ORF30 GENE; CANCER RECURRENCE; CCDC67 GENE; CCNH GENE; FER GENE; FLJ60017 GENE; FOLLOW UP; FUSION GENE; GENE SEQUENCE; GENOME; GLEASON SCORE; GRIK2 GENE; HUMAN; KDM4 GENE; LRRC59 GENE; MAJOR CLINICAL STUDY; MALE; MAN2A1 GENE; METASTASIS; MTOR GENE; NOMOGRAM; ORGAN DONOR; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RNA SEQUENCE; SLC45A2 GENE; TMEM135 GENE; TP53BP1 GENE; TRMT11 GENE; ADULT; AGED; CANCER GRADING; COHORT ANALYSIS; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; GENE LIBRARY; GENETICS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; PROSTATE; PROSTATE TUMOR; SEQUENCE ALIGNMENT; TUMOR RECURRENCE; YOUNG ADULT;

ADULT; AGED; COHORT STUDIES; FOLLOW-UP STUDIES; GENE FUSION; GENE LIBRARY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RNA, MESSENGER; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; TRANSCRIPTOME; YOUNG ADULT;

EID: 84922441951     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.06.025     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin 2012, 62:10-29.
3. Li H, Durbin R: Fast and accurate short read alignment with Burrows- Wheeler transform. Bioinformatics 2009, 25:1754-1760.
4. Yu YP, Ding Y, Chen R, Liao SG, Ren BG, Michalopoulos A, Michalopoulos G, Nelson J, Tseng GC, Luo JH: Whole-genome methylation sequencing reveals distinct impact of differential methylations on gene transcription in prostate cancer. Am J Pathol 2013, 183: 1960-1970.
5. Luo JH, Ding Y, Chen R, Michalopoulos G, Nelson J, Tseng G, Yu YP: Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer. Am J Pathol 2013, 182: 2028-2036.
6. Yu YP, Song C, Tseng G, Ren BG, Laframboise W, Michalopoulos G, Nelson J, Luo JH: Genome abnormalities precede prostate cancer and predict clinical relapse. Am J Pathol 2012, 180:2240-2248.
7. Edgren H, Murumagi A, Kangaspeska S, Nicorici D, Hongisto V, Kleivi K, Rye IH, Nyberg S, Wolf M, Borresen-Dale AL, Kallioniemi O: Identification of fusion genes in breast cancer by paired-end RNA-sequencing. Genome Biol 2011, 12:R6.
8. Prakash T, Sharma VK, Adati N, Ozawa R, Kumar N, Nishida Y, Fujikake T, Takeda T, Taylor TD: Expression of conjoined genes: Another mechanism for gene regulation in eukaryotes. PLoS One 2010, 5:e13284.
9. Zeng W, Fu C-W, Arisona SM, Qu H: Visualizing interchange patterns in massive movement data. Computer Graphics Forum, Proceedings of EuroVis 2013, 32:3, part 3, 271-280.
10. Youden WJ: Index for rating diagnostic tests. Cancer 1950, 3:32-35.
11. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Müller M: PROC: An open-source package for R and S to analyze and compare ROC curves. BMC Bioinformatics 2011, 12:77.
12. Luo JH, Yu YP, Cieply K, Lin F, Deflavia P, Dhir R, Finkelstein S, Michalopoulos G, Becich M: Gene expression analysis of prostate cancers. Mol Carcinog 2002, 33:25-35.
13. Yu YP, Landsittel D, Jing L, Nelson J, Ren B, Liu L, McDonald C, Thomas R, Dhir R, Finkelstein S, Michalopoulos G, Becich M, Luo JH: Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol 2004, 22:2790-2799.
14. Ren B, Yu G, Tseng GC, Cieply K, Gavel T, Nelson J, Michalopoulos G, Yu YP, Luo JH: MCM7 amplification and overexpression are associated with prostate cancer progression. Oncogene 2006, 25:1090-1098.
15. Yu YP, Yu G, Tseng G, Cieply K, Nelson J, Defrances M, Zarnegar R, Michalopoulos G, Luo JH: Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer Res 2007, 67:8043-8050.
16. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, Varambally S, Cao X, Tchinda J, Kuefer R, Lee C, Montie JE, Shah RB, Pienta KJ, Rubin MA, Chinnaiyan AM: Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005, 310:644-648.
17. Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, Sivachenko AY, et al: The genomic complexity of primary human prostate cancer. Nature 2011, 470:214-220.
18. Baca SC, Prandi D, Lawrence MS, Mosquera JM, Romanel A, Drier Y, et al: Punctuated evolution of prostate cancer genomes. Cell 2013, 153:666-677.
19. Sinclair PB, Sorour A, Martineau M, Harrison CJ, Mitchell WA, O'Neill E, Foroni L: A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: Identification and analysis of a candidate tumor suppressor gene. Cancer Res 2004, 64:4089-4098.
20. Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, Partin AW: Death in patients with recurrent prostate cancer after radical prostatectomy: Prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality. J Clin Oncol 2007, 25:1765-1771.
21. Antonarakis ES, Zahurak ML, Lin J, Keizman D, Carducci MA, Eisenberger MA: Changes in PSA kinetics predict metastasis-free survival in men with PSA-recurrent prostate cancer treated with nonhormonal agents: combined analysis of 4 phase II trials. Cancer 2012, 118:1533-1542.
22. Towns WL, Begley TJ: Transfer RNA methytransferases and their corresponding modifications in budding yeast and humans: Activities, predications, and potential roles in human health. DNA Cell Biol 2012, 31:434-454.
23. Misago M, Liao YF, Kudo S, Eto S, Mattei MG, Moremen KW, Fukuda MN: Molecular cloning and expression of cDNAs encoding human alpha-mannosidase II and a previously unrecognized alpha-mannosidase IIx isozyme. Proc Natl Acad Sci U S A 1995, 92:11766-11770.
24. Fisher RP, Morgan DO: A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 1994, 78:713-724.
25. Yang H, Rudge DG, Koos JD, Vaidialingam B, Yang HJ, Pavletich NP: MTOR kinase structure, mechanism and regulation. Nature 2013, 497:217-223.
26. Wang H, Luo K, Tan LZ, Ren BG, Gu LQ, Michalopoulos G, Luo JH, Yu YP: P53-Induced gene 3 mediates cell death induced by glutathione peroxidase 3. J Biol Chem 2012, 287:16890-16902.
27. Zhen Y, Sorensen V, Skjerpen CS, Haugsten EM, Jin Y, Walchli S, Olsnes S, Wiedlocha A: Nuclear import of exogenous FGF1 requires the ER-protein LRRC59 and the importins Kpnalpha1 and Kpnbeta1. Traffic 2012, 13:650-664.
28. Yang J, Jubb AM, Pike L, Buffa FM, Turley H, Baban D, Leek R, Gatter KC, Ragoussis J, Harris AL: The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a keymediator of estrogen induced growth. Cancer Res 2010, 70:6456-6466.
29. Savolainen K, Kotti TJ, Schmitz W, Savolainen TI, Sormunen RT, Ilves M, Vainio SJ, Conzelmann E, Hiltunen JK: A mouse model for alpha-methylacyl-CoA racemase deficiency: Adjustment of bile acid synthesis and intolerance to dietary methyl-branched lipids. Hum Mol Genet 2004, 13:955-965.
30. Krolewski JJ, Lee R, Eddy R, Shows TB, Dalla-Favera R: Identification and chromosomal mapping of new human tyrosine kinase genes. Oncogene 1990, 5:277-282.